Veeva Systems Inc. (NYSE:VEEV) Receives Average Recommendation of "Moderate Buy" from Analysts

Key Points

• Analyst consensus: Twenty-six analysts give Veeva an average rating of "Moderate Buy" (1 sell, 8 hold, 16 buy, 1 strong buy) with a 12‑month average price target of about $278.70.
• Recent results and guidance: Veeva beat estimates with $2.06 EPS versus $1.94 expected and $835.95M revenue (up 16% YoY), and set FY2027 guidance around $8.85 EPS with Q1 2027 guidance of $2.13–$2.14.
• Capital allocation and ownership: The board approved a $2.0 billion buyback (up to 5.5% of shares), insiders own 10.3% (with a director recently selling 750 shares), and institutional investors hold about 88.2% of the stock.

Shares of Veeva Systems Inc. (NYSE:VEEV - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the twenty-six research firms that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokers that have issued ratings on the stock in the last year is $278.6957.

A number of equities research analysts have weighed in on VEEV shares. Piper Sandler lowered their price objective on Veeva Systems from $355.00 to $285.00 and set an "overweight" rating for the company in a research note on Thursday, March 5th. Barclays decreased their price target on shares of Veeva Systems from $305.00 to $250.00 and set an "overweight" rating for the company in a research report on Wednesday, February 25th. Stifel Nicolaus raised their price target on shares of Veeva Systems from $212.00 to $245.00 and gave the stock a "buy" rating in a research report on Thursday, March 5th. Morgan Stanley raised their price target on shares of Veeva Systems from $205.00 to $215.00 and gave the stock an "equal weight" rating in a research report on Thursday, March 5th. Finally, Canaccord Genuity Group decreased their price objective on shares of Veeva Systems from $280.00 to $235.00 and set a "hold" rating for the company in a report on Thursday, March 5th.

Insider Buying and Selling

In related news, Director Priscilla Hung sold 750 shares of Veeva Systems stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $153.50, for a total value of $115,125.00. Following the completion of the transaction, the director directly owned 4,003 shares in the company, valued at approximately $614,460.50. This trade represents a 15.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 10.30% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in Veeva Systems by 3.1% in the third quarter. Vanguard Group Inc. now owns 15,429,231 shares of the technology company's stock worth $4,596,522,000 after purchasing an additional 457,806 shares during the period. Alliancebernstein L.P. boosted its holdings in Veeva Systems by 4.1% in the third quarter. Alliancebernstein L.P. now owns 5,941,631 shares of the technology company's stock worth $1,770,071,000 after purchasing an additional 235,983 shares during the period. Principal Financial Group Inc. boosted its holdings in Veeva Systems by 0.6% in the fourth quarter. Principal Financial Group Inc. now owns 3,870,293 shares of the technology company's stock worth $863,978,000 after purchasing an additional 23,416 shares during the period. State Street Corp boosted its holdings in Veeva Systems by 2.4% in the fourth quarter. State Street Corp now owns 3,589,425 shares of the technology company's stock worth $801,267,000 after purchasing an additional 85,695 shares during the period. Finally, JPMorgan Chase & Co. boosted its holdings in Veeva Systems by 4.8% in the third quarter. JPMorgan Chase & Co. now owns 3,476,258 shares of the technology company's stock worth $1,035,622,000 after purchasing an additional 159,984 shares during the period. Institutional investors and hedge funds own 88.20% of the company's stock.

Veeva Systems Trading Up 10.1%

VEEV opened at $171.70 on Friday. The company has a fifty day simple moving average of $174.70 and a 200 day simple moving average of $216.76. The firm has a market cap of $28.04 billion, a price-to-earnings ratio of 31.74, a PEG ratio of 0.77 and a beta of 0.93. Veeva Systems has a twelve month low of $148.05 and a twelve month high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its earnings results on Wednesday, March 4th. The technology company reported $2.06 earnings per share for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $835.95 million during the quarter, compared to the consensus estimate of $810.95 million. Veeva Systems had a return on equity of 13.80% and a net margin of 28.44%.The company's revenue was up 16.0% on a year-over-year basis. During the same period last year, the firm earned $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. On average, analysts forecast that Veeva Systems will post 6.41 earnings per share for the current fiscal year.

Veeva Systems declared that its Board of Directors has authorized a stock buyback program on Monday, January 5th that authorizes the company to buyback $2.00 billion in shares. This buyback authorization authorizes the technology company to purchase up to 5.5% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board of directors believes its shares are undervalued.

About Veeva Systems

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.